Better days are coming for Riley-Day patients

Journal of Molecular Medicine

Volumn 85, Issue 2, 2007, Pages 99-101

  Luft, F C ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; I KAPPA B KINASE; KINETIN; NORADRENALIN; SMALL NUCLEAR RNA;

ALTERNATIVE RNA SPLICING; AUTONOMIC NEUROPATHY; AUTOSOMAL RECESSIVE DISORDER; DIGESTIVE SYSTEM FUNCTION DISORDER; DYSAUTONOMIA; DYSPHAGIA; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; NONHUMAN; ORTHOSTATIC HYPOTENSION; SHORT SURVEY; SPLICEOSOME; SWEAT GLAND DISEASE; VASOMOTOR DISORDER; VOMITING;

ALTERNATIVE SPLICING; DYSAUTONOMIA, FAMILIAL; HUMANS; KINETIN;

EID: 33846628898     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-006-0144-3     Document Type: Short Survey

References (16)

1. Riley CM, Day RL, Greeley D, Langford WS (1949) Central autonomic dysfunction with defective lacrimation. Report of 5 cases. Pediatrics 3:468-477
2. Axelrod FB (2004) Familial dysautonomia. Muscle Nerve 29:352-363
3. Gold-von Simson G, Rutkowski M, Berlin D, Axelrod FB (2005) Pacemakers in patients with familial dysautonomia: A review of experience with 20 patients. Clinic Auton Res 15:15-20
4. Hims MM, Ibrahim EC, Leyne M, Mull J, Liu L, Lazaro C, Shetty RS, Gill S, Gusella JF, Reed R, Slaugenhaupt SA (2007) Therapeutic potential and mechanisms of kinetin as a treatment for the human splicing disease, familial dysautonomia. J Mol Med 109-144. DOI 10.1007/s00109-006-0137-2
5. Faustino NA, Cooper TA (2003) PremRNA splicing and human disease. Genes Dev 17:419-437
6. Will CL, Luhrmann R (2001) Spliceosomal UsnRNP biogenesis, structure and function. Curr Opin Cell Biol 13:290-301
7. Graveley BR (2000) Sorting out the complexity of SR protein functions. RNA 6:1197-1211
8. Nissim-Rafinia M, Chiba-Falek O, Sharon G, Boss A, Kerem B (2000) Cellular and viral splicing factors can modify the splicing pattern of CFTR transcripts carrying splicing mutations. Hum Mol Genet 9:1771-1778
9. Chang JG, Hsieh-Li HM, Jong YJ, Wang NM, Tsai CH, Li H (2001) Treatment of spinal muscular atrophy by sodium butyrate. Proc Natl Acad Sci USA 98:9808-9813
10. Andreassi C, Jarecki J, Zhou J, Coovert DD, Monani UR, Chen X, Whitney M, Pollok B, Zhang M, Androphy E et al (2001) Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients. Hum Mol Genet 10:2841-2849
11. Zhang ML, Lorson CL, Androphy EJ, Zhou J (2001) An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA. Gene Ther 8:1532-1538
12. Sumner CJ, Huynh TN, Markowitz JA, Perhac JS, Hill B, Coovert DD, Schussler K, Chen X, Jarecki J, Burghes AH et al (2003) Valproic acid increases SMN levels in spinal muscular atrophy patient cells. Ann Neurol 54:647-654
13. Heemskerk J, Tobin AJ, Bain LJ (2002) Teaching old drugs new tricks. Meeting of the Neurodegeneration Drug Screening Consortium, 7-8 April 2002, Washington, DC, USA. Trends Neurosci 25:494-496
14. Stanley N, Muthiah PT, Geib SJ (2003) N6-furfuryladenine (kinetin) hydrochloride. Acta Crystallogr C 59 (Pt 1):o27-o29
15. Slaugenhaupt SA, Mull J, Leyne M, Cuajungco MP, Gill SP, Hims MM, Quintero F, Axelrod FB, Gusella JF (2004) Rescue of a human mRNA splicing defect by the plant cytokinin kinetin. Hum Mol Genet 13:429-436
16. Barciszewski J, Massino F, Clark BF (2006) Kinetin: a multiactive molecule. Int J Biol Macromol (in press)